Literature DB >> 10933057

Invasiveness of hepatocellular carcinoma cell lines: contribution of membrane-type 1 matrix metalloproteinase.

K Murakami1, R Sakukawa, T Ikeda, T Matsuura, S Hasumura, S Nagamori, Y Yamada, I Saiki.   

Abstract

Intrahepatic metastasis is one of the malignant features of hepatocellular carcinoma (HCC). Matrix metalloproteinases (MMPs) and urokinase-type plasminogen activator (u-PA)/plasmin, are known to be associated with the invasive properties of various types of tumor cells. In this study, we examined which proteinases play a role in the metastatic invasion of human HCC cell lines. JHH-5 and JHH-6 cells constitutively expressed mRNAs for both membrane-type 1 matrix metalloproteinase (MT1-MMP) and u-PA and invaded through reconstituted MATRIGEL in vitro, whereas JHH-7 cells expressed u-PA mRNA but not MT1-MMP and did not invade. However, hepatocyte growth factor (HGF) induced MT1-MMP expression on the surface of JHH-7 cells and markedly increased invasiveness of JHH-7 in a concentration-dependent manner. Moreover, cleavage activity for pro-MMP-2 was induced in HGF-treated JHH-7 cells. MMP inhibitor, rather than serine proteinase inhibitor, potently inhibited HCC cell invasion. Intrahepatic injection of HCC cell lines into athymic nude mice caused visible intrahepatic metastases in vivo. Moreover, JHH-7 tumors showed expression of MT1-MMP mRNA, while in vitro cultured JHH-7 cells did not. These findings suggest that MT1-MMP plays an important role in the invasive properties of HCC cells, and that HGF modifies the invasive properties of noninvasive HCC cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10933057      PMCID: PMC1508115          DOI: 10.1038/sj.neo.7900046

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  41 in total

1.  Hepatocyte growth factor concentrations after liver resection.

Authors:  M Sakon; M Monden; M Gotoh; T Kanai; K Umeshita; T Mori; H Tsubouchi; Y Daikuhara
Journal:  Lancet       Date:  1992-03-28       Impact factor: 79.321

Review 2.  Biology and biochemistry of proteinases in tumor invasion.

Authors:  P Mignatti; D B Rifkin
Journal:  Physiol Rev       Date:  1993-01       Impact factor: 37.312

3.  The human urokinase-plasminogen activator gene and its promoter.

Authors:  A Riccio; G Grimaldi; P Verde; G Sebastio; S Boast; F Blasi
Journal:  Nucleic Acids Res       Date:  1985-04-25       Impact factor: 16.971

4.  Integration of hepatitis B virus DNA into cells of six established human hepatocellular carcinoma cell lines.

Authors:  K Fujise; S Nagamori; S Hasumura; S Homma; H Sujino; T Matsuura; K Shimizu; M Niiya; H Kameda; K Fujita
Journal:  Hepatogastroenterology       Date:  1990-10

5.  Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product.

Authors:  D P Bottaro; J S Rubin; D L Faletto; A M Chan; T E Kmiecik; G F Vande Woude; S A Aaronson
Journal:  Science       Date:  1991-02-15       Impact factor: 47.728

6.  Regulation of cell growth and motility by hepatocyte growth factor and receptor expression in various cell species.

Authors:  H Tajima; K Matsumoto; T Nakamura
Journal:  Exp Cell Res       Date:  1992-10       Impact factor: 3.905

7.  cDNA for Mo3, a monocyte activation antigen, encodes the human receptor for urokinase plasminogen activator.

Authors:  H Y Min; R Semnani; I F Mizukami; K Watt; R F Todd; D Y Liu
Journal:  J Immunol       Date:  1992-06-01       Impact factor: 5.422

Review 8.  Plasminogen activation: biochemistry, physiology, and therapeutics.

Authors:  T C Wun
Journal:  Crit Rev Biotechnol       Date:  1988       Impact factor: 8.429

Review 9.  Growth factors in the regulation of plasminogen-plasmin system in tumor cells.

Authors:  J Keski-Oja; K Koli; J Lohi; M Laiho
Journal:  Semin Thromb Hemost       Date:  1991-07       Impact factor: 4.180

10.  Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth.

Authors:  F Bussolino; M F Di Renzo; M Ziche; E Bocchietto; M Olivero; L Naldini; G Gaudino; L Tamagnone; A Coffer; P M Comoglio
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

View more
  6 in total

Review 1.  Moving toward an understanding of the metastatic process in hepatocellular carcinoma.

Authors:  W M Korn
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

2.  Solitary lung tumors and their spontaneous metastasis in athymic nude mice orthotopically implanted with human non-small cell lung cancer.

Authors:  T Yamaura; K Murakami; Y Doki; S Sugiyama; T Misaki; Y Yamada; I Saiki
Journal:  Neoplasia       Date:  2000 Jul-Aug       Impact factor: 5.715

Review 3.  Proprotein convertases in tumor progression and malignancy: novel targets in cancer therapy.

Authors:  Abdel-Majid Khatib; Géraldine Siegfried; Michel Chrétien; Peter Metrakos; Nabil G Seidah
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

4.  Gene expression patterns in human liver cancers.

Authors:  Xin Chen; Siu Tim Cheung; Samuel So; Sheung Tat Fan; Christopher Barry; John Higgins; Kin-Man Lai; Jiafu Ji; Sandrine Dudoit; Irene O L Ng; Matt Van De Rijn; David Botstein; Patrick O Brown
Journal:  Mol Biol Cell       Date:  2002-06       Impact factor: 4.138

5.  The expression of CD90/Thy-1 in hepatocellular carcinoma: an in vivo and in vitro study.

Authors:  Caecilia Hapsari Ceriapuri Sukowati; Beatrice Anfuso; Giuliano Torre; Paola Francalanci; Lory Saveria Crocè; Claudio Tiribelli
Journal:  PLoS One       Date:  2013-10-08       Impact factor: 3.240

6.  PROX1 is a transcriptional regulator of MMP14.

Authors:  Silvia Gramolelli; Jianpin Cheng; Ines Martinez-Corral; Markus Vähä-Koskela; Endrit Elbasani; Elisa Kaivanto; Ville Rantanen; Krista Tuohinto; Sampsa Hautaniemi; Mark Bower; Caj Haglund; Kari Alitalo; Taija Mäkinen; Tatiana V Petrova; Kaisa Lehti; Päivi M Ojala
Journal:  Sci Rep       Date:  2018-06-22       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.